SPRY4-IT1 has been seen to sponge at least three different miRNAs in several types of cancers (122–124, 130–134), so it is possible that emerging interactions with other miRNAs could mechanistically explain SPRY4-IT1 role in TGCTs. This evidence concerns the gene SPRY4 and cancer.